HomeTagsHanchorBio Inc

Tag: HanchorBio Inc

spot_imgspot_img
Medical

HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101

HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines to treat a wide variety of patients suffering...
Medical

HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies

HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines, and Shanghai Henlius Biotech, Inc., a global biopharmaceutical...
Medical

HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today...
Medical

HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

HanchorBio Received IND Clearance of HCB101 Multi-regional Clinical Trial By US FDA HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img